Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroblastoma Study Phase II Study of Various Therapies in Patients With Neuroblastoma

NCT00017225 is registered in ClinicalTrials.gov with German Society for Pediatric Oncology and Hematology GPOH gGmbH as lead sponsor.

NCT NCT00017225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00017225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroblastoma Study Phase II Study of Various Therapies in Patients With Neuroblastoma
Lead sponsor
German Society for Pediatric Oncology and Hematology GPOH gGmbH
Phase
Phase 2
Overall status
Completed
Start date
May 31, 1997
Completion date
February 28, 2002
Enrollment
Not reported
Sites
94

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma